# A Survey Study of the Treatment and Outcome Management in Patients Diagnosed With Alzheimer's Disease

> **NCT00291421** · — · COMPLETED · sponsor: **Janssen Pharmaceutica N.V., Belgium** · enrollment: 2360 (actual)

## Conditions studied

- Alzheimer Disease
- Dementia
- Nervous System Diseases
- Mental Disorders
- Brain Diseases

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00291421
- **Lead sponsor:** Janssen Pharmaceutica N.V., Belgium
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2002-07
- **Primary completion:** —
- **Final completion:** 2006-05
- **Target enrollment:** 2360 (ACTUAL)
- **Last updated:** 2013-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00291421

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00291421, "A Survey Study of the Treatment and Outcome Management in Patients Diagnosed With Alzheimer's Disease". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00291421. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*